Acquisition of RESORBA® Read More

The Board of AMS (AIM: AMS), the global medical technology company, is pleased to announce today the proposed acquisition of RESORBA, a long established wound care and wound closure business headquartered in Germany for a total cash consideration of €63.8 million (approximately £55 million) on a debt-free, cash-free basis to be paid, in full, on completion.

AMS Acquisition of Corpura B.V. Read More

Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the global medical technology company, today announces that it has acquired the remaining 50.6% of the shares in Corpura B.V. from Recticel its Joint Venture partner for a consideration of 1.5 million plus 0.8 million to repay funding of working capital to Recticel As a result AMS now…